Pharmaceutical Executive October 2017

October 2017 | Volume 37, Issue 10
Pharmaceutical Executive October 2017
From the Editor
As we again highlight a roster of emerging leaders in pharma, I wanted to recognize Pharm Exec's own unique team behind the scenes.
Features
Pharm Exec’s 10th annual list of rising leaders highlights 11 pharma managers who are poised to help chart the industry’s path forward.
What is the true potential of real-world evidence studies and what are the right questions to ask in determining product performance in the marketplace?
Columns
FDA seeks to de-risk research and promote competition to achieve savings for patients and plans.
European Commission talks drug industry investment, health issues during State of the Union.
Today’s model requires a fourth partner—the systems integrator, writes Adam Nelson.
Pharma needs a reeducation on what it means to be compliant.
Special Sponsored Section
By Pharmaceutical Executive Editors
Emerging as a bastion of peace, stability, and resilience in a region increasingly beset by political turbulence and economic stagnation, Colombia has been steadily reinventing itself as a Latin American pioneer and pacesetter, including in the world of healthcare.
native1_300x100
lorem ipsum